Skip Navigation Skip To Footer

Publications

Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease.

Antiel RM, Halpern SD, Stevens EM, Vrecenak JD, Patterson CA, Tchume-Johnson T, Smith-Whitley K, Peranteau WH, Flake AW, Barakat LP

Published

May 1st, 2017

Appears In

Medical Decision Making

External Link

External Link

Abstract

In utero hematopoietic cell transplantation (IUHCT) has curative potential for sickle cell disease (SCD) but carries a risk of fetal demise.

Page 1 Created with Sketch.

We generate high-quality evidence to advance healthcare policies and practices that improve the lives of all people affected by serious illness.